METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER
申请人:Haggerty Timothy J.
公开号:US20140335050A1
公开(公告)日:2014-11-13
The invention features methods, compositions, and kits for the administration of an HSP90 inhibitor, OBAA, flunarizine, aphidicolin, damnacanthal, dantrolene, or an analog thereof, alone, or in combination with, e.g., a TAA, an antigen-binding scaffold (e.g., an antibody, a soluble T cell receptor, or a chimeric receptor) specific for a TAA, a cell (e.g., a white blood cell that targets a cancer cell), and/or an IFN-β receptor agonist or an IFN-γ receptor agonist, for the treatment of cancer.
335. The 11-oxo- and 12-oxo-derivatives of cholest-4-en-3-one
作者:David N. Kirk、Vladimir Petrow
DOI:10.1039/jr9590001691
日期:——
Mochizuki, Proceedings of the Japan Academy, 1956, vol. 32, p. 206,208